focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuantum Pharma Share News (QP.)

  • There is currently no data for QP.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quantum Pharma Profit Surges And Dividend Hiked After Strong Year

Tue, 10th May 2016 07:27

LONDON (Alliance News) - Niche pharmaceuticals company Quantum Pharma PLC on Tuesday said its pretax profit surged in its financial year to the end of January due to lower financing costs as revenue grew.

Quantum said its pretax profit for the year to the end of January was GBP6.2 million, compared to GBP1.1 million a year earlier, mainly due to the group having booked GBP5.6 million in financing costs the year before.

Revenue grew to GBP70.0 million from GBP61.7 million, helped by the acquisitions of Lamda and NuPharm, investments made in its senior management team, the launch of products under its Mucodis range, and the out-licence of its Avitol capsules to a German pharmaceutical company.

The group also delivered significant tender and contract wins in its homecare business and made progress on developing its Biodose Connect product.

Quantum added that its product pipeline has grown significantly, both in terms of size and value.

Quantum will pay a 1.0 pence per share final dividend, taking its total payout to 1.5p. That compares to the 0.25p final dividend only paid out for the previous financial year.

Chief Executive Andrew Scaife said trading so far in 2016 has been strong, giving the group confidence on the outlook for the full current financial year.

"During the past year, we have made progress in developing several key aspects of Quantum Pharma's business, to put in place a strong platform from which the group can deliver its strategy. We have improved the group's infrastructure and management, and reviewed and significantly improved our processes around monitoring and delivery of the product pipeline, in addition to receiving external validation of its potential value," said Scaife.

"I am excited about the potential of the product pipeline and am pleased that, since the year end, we have received marketing authorisations or approvals to launch three new licensed products with five product lines into the UK market," he added.

Shares in Quantum were up 6.2% to 64.50p.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
20 Oct 2016 11:35

Quantum Pharma conditionally raises £15m in accelerated bookbuild

(ShareCast News) - Quantum Pharma confirms its accelerated bookbuild to raise up to £15m has closed successfully, subject to the passing of certain resolutions by shareholders at the company's annual meeting. The company, which noted that it continued to trade in line, believed net proceeds would re

Read more
20 Oct 2016 07:41

Quantum Pharma Raises GBP15 Million To Pay Down Debt (ALLISS)

Read more
4 Oct 2016 09:10

Quantum Pharma's shares plummet as it expects to perform below expectations in H2

(ShareCast News) - Shares in AIM-listed drug manufacturer Quantum Pharma plunged nearly 50% on Tuesday morning as it said it expects the performance in the second half of the year to be "materially below market expectations" although it anticipates "strong" growth. Chief financial officer and acting

Read more
31 Aug 2016 11:48

Quantum Pharma looks to meet FY market expectations

(ShareCast News) - Quantum Pharma has made good progress during its first half, in line with management views, and anticipates meeting market expectations for the full year. "As previously indicated, the group's performance for the year is second-half weighted and will be dependent on the level of s

Read more
10 Aug 2016 07:37

Quantum Pharma's Colonis Launches Peptic Ulcer Treatment

Read more
5 Aug 2016 12:03

Quantum Pharma completes Mucodis range with vaginal cream

(ShareCast News) - Niche pharmaceutical developer Quantum Pharma announced on Friday that its subsidiary Colonis has launched Mucodis vaginal cream. The AIM-traded company said the cream is part of the Mucodis range of in-licensed patented medical devices, which focus on treating some of the side ef

Read more
26 Jul 2016 12:00

Quantum Pharma launches Mucodis Rectal Gel

(ShareCast News) - Quantum Pharma said Colonis has launched its Mucodis Rectal Gel for preventing and treating rectal mucositis, a common side effect of chemotherapy and radiotherapy in cancer patients. Mucositis is a condition characterised by pain and inflammation of the body's mucous membranes wh

Read more
26 Jul 2016 09:35

Quantum Pharma Launches Mucodies Rectal Gel Product

Read more
12 Jul 2016 13:41

Quantum Pharma CEO Scaife steps down, trading in line

(ShareCast News) - Quantum Pharma chief executive Andrew Scaife has stepped down after seven years but is leaving the company with current trading running in line with management expectations. Scaife has decided to leave the Newcastle-upon-Tyne company due to family reasons but has agreed to stay un

Read more
12 Jul 2016 07:31

Quantum Pharma CEO Resigns As First-Half Trading Meets Expectations

Read more
11 Jul 2016 15:47

Quantum Pharma launches third product from its Mucodis range of treatments

(ShareCast News) - Quantum Pharma launched the third product of its Mucodis range for the treatment of some of the side effects suffered by patients undergoing cancer treatment. Mucodis dermal spray, which reached markets on Monday, was targetted at treating radiation-induced dermatitis, a condition

Read more
11 Jul 2016 07:44

Quantum Pharma's Colonis Launches Mucodis Dermal Spray

Read more
5 Jul 2016 15:05

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Jun 2016 07:26

Quantum Pharma Set To Commercialise Biodose Connect Device

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.